Abhishek Pandey Abbvie Global Research Expertise

Two medical professionals in protective gear conversing in a laboratory hallway.
Credit: pexels.com, Two medical professionals in protective gear conversing in a laboratory hallway.

Abhishek Pandey is a highly respected expert in Abbvie's global research efforts. He has played a crucial role in advancing the company's scientific understanding and developing innovative treatments.

With a strong background in research, Abhishek has been instrumental in driving Abbvie's research agenda forward. His expertise has been invaluable in shaping the company's global research strategy.

Abhishek's dedication to Abbvie's research has been recognized through his various roles within the organization.

Intriguing read: Abbvie Company Profile

Global Lead Research Scientist

Abhishek Pandey is the Global Lead and Principal Research Scientist II at AbbVie, specializing in Machine Learning for Drug Discovery.

He leads a team of machine learning scientists focused on developing advanced Machine Learning methods for various aspects of drug discovery.

Abhishek holds a Ph.D. in Electrical and Computer Engineering from the University of Arizona.

Prior to joining AbbVie, Abhishek was a founding member of the AI team at Tempus Labs Inc, now known as Tempus AI.

Explore further: Abbvie Executives

Research Approach

Abhishek Pandey's team at AbbVie is focused on developing advanced machine learning algorithms for Discovery, Developmental Sciences, and the AbbVie-Calico alliance departments.

Credit: youtube.com, HITLAB February Symposium 2025 : Abhishek Pandey

Abhishek Pandey leads a team of machine learning scientists at AbbVie, specializing in Machine Learning for Drug Discovery. His team's work spans cheminformatics, imaging research, multi-omics, and the computation behind many of AbbVie's current partnerships and collaborations.

Abhishek's team at AbbVie is responsible for developing state-of-the-art machine learning algorithms for Discovery, Developmental Sciences, and the AbbVie-Calico alliance departments.

The team's work includes developing PADME (Protein And Drug Molecule interaction prEdiction), a framework based on Deep Neural Networks, to predict real-valued interaction strength between compounds and proteins.

Abhishek Pandey's team at AbbVie is making significant contributions to the field of machine learning for drug discovery.

Here are some key areas where Abhishek's team is making an impact:

  • Target identification and prioritization
  • ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity)
  • De Novo design of molecule
  • Tox (Toxicity)
  • Precision medicine

By developing these advanced machine learning algorithms, Abhishek's team is helping AbbVie streamline its drug discovery process and bring new treatments to market more efficiently.

Frequently Asked Questions

Who is the current CEO of AbbVie?

The current CEO of AbbVie is Rob Michael, who also serves as Chairman of the Board.

Timothy Gutkowski-Stoltenberg

Senior Writer

Timothy Gutkowski-Stoltenberg is a seasoned writer with a passion for crafting engaging content. With a keen eye for detail and a knack for storytelling, he has established himself as a versatile and reliable voice in the industry. His writing portfolio showcases a breadth of expertise, with a particular focus on the freight market trends.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.